Claim 50% Off TipRanks Premium and Invest with Confidence
- Unlock hedge-fund level data and powerful investing tools designed to help you make smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis so your portfolio is always positioned for maximum potential
An update from Vitrafy Life Sciences Ltd. ( (AU:VFY) ) is now available.
Vitrafy Life Sciences Limited has announced a change in the director’s interest, specifically regarding Brenton Owens. The company has granted 275,346 Performance Rights to Owens, as approved at its Annual General Meeting held on November 20, 2025. This change reflects a strategic move to align the interests of the director with the company’s performance, potentially impacting the company’s governance and stakeholder confidence.
The most recent analyst rating on (AU:VFY) stock is a Buy with a A$2.10 price target. To see the full list of analyst forecasts on Vitrafy Life Sciences Ltd. stock, see the AU:VFY Stock Forecast page.
More about Vitrafy Life Sciences Ltd.
Average Trading Volume: 26,040
Technical Sentiment Signal: Strong Sell
Current Market Cap: A$83M
See more data about VFY stock on TipRanks’ Stock Analysis page.